MacroGenics
MGNX
$15.67
Share price
2.96%
Change (1 day)
119.47%
Change (1 year)
Categories
Market capitalization of MacroGenics (MGNX)
Market cap: $0.98 Billion
As of May 2024 MacroGenics has a market cap of $0.98 Billion. This makes MacroGenics the world's 5160th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of MacroGenics from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.98 B | 64.28% |
| 2023 | $0.59 B | 44.66% |
| 2022 | $0.41 B | -58.08% |
| 2021 | $0.98 B | -23.47% |
| 2020 | $1.28 B |
End of Day market cap according to different sources
On May 4th, 2024 the market cap of MacroGenics was reported to be:
$0.98 Billion
$0.98 Billion
$0.97 Billion
$0.98 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $157.47 B | 15,963.61% | 🇺🇸 USA |
 Eli Lilly LLY | $698.51 B | 71,153.98% | 🇺🇸 USA |
 Amgen AMGN | $166.96 B | 16,931.99% | 🇺🇸 USA |
 Gilead Sciences GILD | $80.77 B | 8,140.01% | 🇺🇸 USA |
 Merck MRK | $322.98 B | 32,846.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $89.17 B | 8,996.20% | 🇺🇸 USA |
 Xencor XNCR | $1.48 B | 51.62% | 🇺🇸 USA |